Skip to content
Genialis Logo Genialis Logo Genialis Logo
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch
  • Solutions
    • Therapeutic Intelligence & Biomarker Discovery
    • Genialis™ krasID
    • Genialis™ Expressions
  • Approach
    • Genialis™ Supermodel
    • Genialis ResponderID™
    • Why RNA?
  • Case Studies
  • About Us
    • Meet Our Team
    • Careers
    • Compliance
  • Media
    • News and Events
    • Scientific Publications
    • Press Releases
    • TPM Podcast
  • Get in Touch

Press Releases

Find out the latest announcements and updates from Genialis. This is where you’ll find newest reports on our partnerships, collaborations, and achievements.

Open Media Kit
  • April 9, 2024|

    New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients

  • April 3, 2024|

    Genialis Enlists Two New Partners as It Assembles World’s Most Ethno-Geographically Diverse Cancer Data Sets

  • January 26, 2024|

    Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

  • November 3, 2023|

    Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response

  • October 23, 2023|

    Genialis and Cancer Research Horizons Collaborate to Develop AI-Driven Patient Classifiers

  • September 27, 2023|

    Genialis Presents ResponderID KRAS, a Biomarker Framework for Predicting Patient Response

  • September 8, 2023|

    Clinical Drug Discovery Veterans Join Genialis’ Efforts to Build Better Biomarkers for Precision Oncology

  • August 30, 2023|

    Genialis Maintains ISO 27001 Information Security Certification for Sixth Year

  • August 3, 2023|

    Genialis and BioLab Win Best Regular Paper at the 21st International Conference of Artificial Intelligence in Medicine

Previous12345Next

Genialis, Inc.

68 Harrison Ave #605
PMB 29417
Boston, MA 02111

Get in touch

+1 617 237 0085 (US)
+386 59 054 580 (Slo)
info @ genialis.com
biomarkers @ genialis.com
Genialis LinkedIn

Site map

  • Therapeutic Intelligence & Biomarker Discovery
  • Genialis™ krasID
  • Genialis™ Expressions
  • Why RNA
  • Genialis ResponderID™
  • Genialis™ Supermodel
  • Case Studies
  • Meet Our Team
  • Careers
  • Compliance

Media

  • News and Events
  • Scientific Publications
  • Press Releases
  • Talking Precision Medicine Podcast
Subscribe to our newsletter

Genialis is a founding member of the Alliance for AI in Healthcare

Alliance for Artificial Intelligence in Healthcare AAIH logo
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.
  • Privacy Policy
  • Terms of Service
  • Genialis d.o.o.

Copyright © Genialis, Inc.

Page load link

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.

Links & Downloads

Genialis Logo
Leadership Headshots
Talking Precision Medicine Info Sheet
Leadership Team
linkedin.com/company/genialis

Media Contact

Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025.  Read the press release →               

Subscribe to Genialis updates and information

Thanks for subscribing!
There was an error trying to subscribe. Please try again later.
This website uses cookies and third party services. Read More Accept Reject